BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...

A small Canadian province feared it had a mystery neurological illness on its hands. The search for answers set off a battle for the truth.

Discover how Aga Khan University Hospital in Kenya is transforming healthcare in Africa by tackling brain drain and ...

A small Canadian province feared it had a mystery neurological illness on its hands. The search for answers set off a battle for the truth.

Neuroinfectious diseases, encephalitis, and neuroinflammation represent a diverse group of conditions that significantly ...

By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), highlighting several recent developments.

When most people think about aging, they imagine a linear progression towards an inevitable end. They think in terms of birthdays, knowing that the more candles on the cake, the more we should ...

An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...

Audio Timeline Slider: Use the left or right arrow keys to decrease or increase the slider value. Developed in 2015 by researchers studying the effects of diet on brain function and cognitive decline, ...

According to Precedence Research, the global AI in medical imaging market size is calculated at USD 2.57 trillion in 2026 and ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...